发明名称 Mass spectrometric methods for quantifying NPY 1-36 and NPY 3-36
摘要 Provided are methods of detecting the presence or amount of NPY 1-36 or NPY 3-36 in a sample using mass spectrometry. Importantly, by methods of the invention, both NPY 1-36 and NPY 3-36 can be quantified simultaneously, separately, and independently in a sample that contains both peptides. The methods provide enhanced specificity, and excellent sensitivity with limits of quantitation (LOQ) of about 0.1 ng/mL, and are accomplished in less time and with less sample preparation than required in other assays for NPY. In certain embodiments, because the methods of the invention are specific for both NPY 1-36 and NPY 3-36, the methods provide a major advantage over existing immunoassays. Therefore, the methods may be used to obtain reliable concentration data in several important patient populations, such as patients with hypertension, heart disease, or cancer.
申请公布号 US9269550(B2) 申请公布日期 2016.02.23
申请号 US201113811537 申请日期 2011.07.22
申请人 Georgetown University 发明人 Soldin Steven J.
分类号 H01J49/00;G01N33/68 主分类号 H01J49/00
代理机构 Foley Hoag LLP 代理人 Steele Alan W.;Foley Hoag LLP
主权项 1. A method of assaying for NPY 1-36 and a fragment of NPY 1-36, which method comprises: a) preparing a test sample, wherein the test sample comprises NPY 1-36 and a fragment of NPY 1-36; b) combining the test sample with a known quantity of a first reference peptide for the NPY 1-36 and a second reference peptide for the fragment of NPY 1-36, thereby forming a test sample comprising an internal standard for each of the NPY 1-36 and the fragment of NPY 1-36; and c) determining by mass spectrometry the quantity of the NPY 1-36 and the fragment of NPY 1-36 in the test sample and the quantity of each of the first and second reference peptides in the test sample, and calibrating the quantity of the NPY 1-36 against the known and determined quantities of the first reference peptide in the test sample and the quantity of the fragment of NPY 1-36 in the test sample against the known and determined quantities of the second reference peptide in the test sample, thereby determining the absolute quantity or absolute concentration of the NPY 1-36 and the fragment of NPY 1-36 in the test sample, wherein the first reference peptide is NPY 1-36, human NPY 1-36, porcine NPY 1-36, or isotopically labeled NPY 1-36; and the second reference peptide is isotopically labeled NPY 3-36.
地址 Washington DC US